Literature DB >> 25813063

The hospital costs of stroke patients in Chinese island populations: an 11-year tendency analysis.

Xiaomei Wu1, Safeng Zou2, Bo Zhu3, Jingpu Shi4.   

Abstract

BACKGROUND: The impact of stroke is devastating the life of patients, families, and even the communities. The cost of treatment; however, has the tendency of increasing nowadays, which has brought a heavy burden to patients and their families. Our study aims to collect the data of the hospital cost among stroke patients in Chinese island populations over the past decade and provide the scientific improvement for stroke.
METHODS: We retrospectively collected the basic information and hospital costs of the stroke patients in Dalian Changhai Hospital from 2003 to 2013 using the Information Registration System of Inpatient.
RESULTS: The total cumulative hospital admissions for stroke in Dalian Changhai Hospital were 1367 and showed a rising tendency from 2003 to 2013. Our results illustrated that the annual cumulative hospital costs of stroke inpatients increased rapidly in the past 11 years (the average rise was 37.71% per year), and the mean hospital cost per admission was 1.66% higher than that before, when the mean length of hospital days showed a downward tendency. Medication cost was found to be the largest part in the overall hospital cost (as a high percentage of 73.94%); however, traditional Chinese medicine only occupied quite a small proportion in the medicines.
CONCLUSIONS: The hospital cost for stroke in Dalian Changhai County has brought an increasingly heavy economic burden to the local government and residents.
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chinese island populations; Stroke; hospital cost; tendency analysis

Mesh:

Year:  2015        PMID: 25813063     DOI: 10.1016/j.jstrokecerebrovasdis.2014.12.021

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  4 in total

1.  Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the 2017 Hypertension Clinical Practice Guidelines.

Authors:  Yan-Feng Zhou; Na Liu; Pei Wang; Jae Jeong Yang; Xing-Yue Song; Xiong-Fei Pan; Xiaomin Zhang; Meian He; Honglan Li; Yu-Tang Gao; Yong-Bing Xiang; Tangchun Wu; Danxia Yu; An Pan
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

2.  Prevalence and risk factors of stroke in a rural area of northern China: a 10-year comparative study.

Authors:  Ling-Yun Ma; Xiao-Dan Wang; Shuai Liu; Jinghuan Gan; Wenzheng Hu; Zhichao Chen; Jiuyan Han; Xiaoshan Du; Han Zhu; Zhihong Shi; Yong Ji
Journal:  Aging Clin Exp Res       Date:  2021-12-02       Impact factor: 3.636

3.  Psychometric properties of the Chinese version of the Self-Efficacy for Appropriate Medication Use Scale in patients with stroke.

Authors:  Xiao-Fang Dong; Yan-Jin Liu; Ai-Xia Wang; Pei-Hua Lv
Journal:  Patient Prefer Adherence       Date:  2016-03-14       Impact factor: 2.711

4.  Hospitalization costs among immobile patients with hemorrhagic or ischemic stroke in China: a multicenter cross-sectional study.

Authors:  Hongpeng Liu; Chen Zhu; Jing Cao; Jing Jiao; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xinjuan Wu
Journal:  BMC Health Serv Res       Date:  2020-09-29       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.